Imperative Care
- Industry
- Medical Equipment Manufacturing
- Founded Year
- 2015
- Headquarters
- Campbell, California, United States
- Employee Count
- 379
Key People
- Farhad Khosravi - Co-Founder, Chief Executive Officer & Chairman
- Daniel Davis - Chief Strategy Officer & Co-Chief Operating Officer
- Yi Yang - Co-Founder & Chief Technology Officer
- Scott Elliott - Chief Legal Officer & Executive Vice President
- Carole Roth - Chief People Officer
Assessment
- Team
-
Aspect: Multiple successful MedTech entrepreneurs
Summary: The leadership team comprises experienced professionals with successful backgrounds in medical technology.
A strong leadership team with a proven track record in MedTech enhances the company's ability to navigate challenges and seize opportunities in the medical device industry.
- Clinical Need
-
Aspect: Very Strong
Summary: Imperative Care addresses critical gaps in stroke and vascular disease treatment.
By targeting urgent unmet needs in stroke and vascular care, Imperative Care is positioned to make a substantial impact on patient outcomes and healthcare practices.
- Competition
-
Aspect: Very crowded + Strategics
Summary: The market for stroke and vascular devices is highly competitive with numerous established players.
Operating in a crowded market with strategic competitors requires differentiation and robust strategies to capture market share.
- Technical Challenge
-
Aspect: Moderate
Summary: Developing innovative stroke treatment devices involves moderate technical challenges.
The technical hurdles in developing stroke treatment devices are significant but can be overcome with a skilled team and adequate resources.
- Patent
-
Aspect: Strong
Summary: Imperative Care holds a substantial patent portfolio with a high percentage of active patents.
A robust patent portfolio protects the company's innovations and supports its market position by preventing competitors from easily replicating its technologies.
- Financing
-
Aspect: Well-funded
Summary: The company has secured significant funding through multiple investment rounds.
Adequate funding enables the company to invest in research, development, and commercialization efforts, facilitating growth and innovation.
- Regulatory
-
Aspect: 510k/PMA
Summary: Imperative Care has obtained necessary regulatory approvals for its products.
Securing regulatory approvals is crucial for commercializing medical devices, ensuring compliance with safety and efficacy standards.
Opportunity Rollup
- Odds of Success
- 3.2
- Peak Market Share
- 3.8
- Segment CAGR
- 9.4%
- Market Segment
- Neurology Devices
- Market Sub Segment
- Clot Management Devices
| Year Post Launch | Market Penetration (%) |
|---|---|
| 1 | 0.19 |
| 2 | 0.57 |
| 3 | 1.33 |
| 4 | 2.66 |
| 5 | 3.80 |
Key Takeaway
Imperative Care is well-positioned in the growing stroke treatment market, but must navigate intense competition and regulatory challenges to achieve success.